An official website of the United States government

This repository is under review for potential modification in compliance with Administration directives.

Publication Information

PubMed ID
Public Release Type
Journal
Publication Year
2018
Authors
Henry P Parkman, Erin K Hallinan, William L Hasler, Gianrico Farrugia, Kenneth L Koch, Linda Nguyen, William J Snape, Thomas L Abell, Richard W McCallum, Irene Sarosiek, Pankaj J Pasricha, John Clarke, Laura Miriel, James Tonascia, Frank Hamilton
Studies

Abstract

Background Early satiety (ES) and postprandial fullness (PPF) are often present in gastroparesis, but the importance of these symptoms in gastroparesis has not been well described. The aims were: 1) Characterize ES and PPF in patients with gastroparesis. 2) Assess relationships of ES and PPF with etiology of gastroparesis, quality of life, body weight, gastric emptying, and water load testing. Methods Gastroparetic patients filled out questionnaires assessing symptoms (PAGI-SYM) and quality of life (PAGI-QOL, SF-36v2). Patients underwent gastric emptying scintigraphy and water load testing. Key Results 198 patients with gastroparesis (134 IG, 64 DG) were evaluated. ES was severe or very severe in 50% of patients. PPF was severe or very severe in 60% of patients. Severity scores for ES and PPF were similar between idiopathic and diabetic gastroparesis. Increasing severity of ES and PPF were associated with other gastroparesis symptoms including nausea/vomiting, satiety/early fullness, bloating, and upper abdominal pain and GERD subscores. Increasing severity of ES and PPF were associated with increasing gastroparesis severity, decreased BMI, decreased quality of life from PAGI-QOL and SF-36 physical health. Increasing severity of ES and PPF were associated with increasing gastric retention of a solid meal and decreased volume during water load test. Conclusions & Inferences ES and PPF are commonly severe symptoms in both diabetic and idiopathic gastroparesis. ES and PPF severity are associated with other gastroparesis symptom severities, body weight, as well as quality of life, gastric emptying, water load testing. Thus, ES and PPF are important symptoms characterizing gastroparesis. ClinicalTrials.gov number: NCT NCT01696747